National Security Commission on Emerging Biotechnology
| Commission overview | |
|---|---|
| Formed | 2022; 3 years ago (2022) |
| Commission executive |
|
| Parent department | United States Department of Defense |
| Website | Official website |
The National Security Commission on Emerging Biotechnology (NSCEB) is a bipartisan U.S. legislative commission established by Congress in the 2022 National Defense Authorization Act.[1]
The NSCEB reviews how emerging biotechnology affects U.S. Department of Defense activities. It submits an interim report within one year and a final unclassified report within two years, including recommendations for Congress and the federal government.[2]
The National Security Commission on Emerging Biotechnology was announced in March 2022.[3] It will issue its report and recommendations to Congress in 2025.[4]
Commissioners
[edit ]The NSCEB is composed of appointed commissioners:
- Senator Todd Young (R-IN), Chair [5] [6] [7]
- Dr. Michelle Rozo, Vice Chair[8]
- Senator Alex Padilla (D-CA)[9]
- Representative Stephanie Bice (R-OK)[10]
- Representative Ro Khanna (D-CA)[11]
- Dov S. Zakheim - former Under Secretary of Defense (Comptroller) [12]
- Paul Arcangeli [2] [13]
- Dr. Alexander Titus - former Assistant Director for Biotechnology in the Office of the Under Secretary of Defense for Research and Engineering [14]
- Dr. Eric Schmidt - Billionaire philanthropist and former CEO of Google
- Dr. Angela Belcher [15]
- Dawn Meyerriecks [16]
Reports and policy recommendations
[edit ]The Commission submitted its first report to Congress in December 2023[17] which included recommendations related to agriculture policy for potential inclusion in the Farm Bill.[18]
In December 2023, NSCEB published its interim report, which discusses the potential applications of biotechnology in fields such as human health, food security, energy production, and economic development. The report stresses the need for the U.S. to stay ahead in biotechnology as international competition increases.[19]
In January 2024, the Commission published white papers on the integration of artificial intelligence and biotechnology ("AIxBio").[20] The Commission noted that AIxBio research would transform the speed and scope of emerging biotechnology innovation.[21]
In May 2024, members of Congress introduced several pieces of legislation recommended by the Commission focused on food security and agricultural security.[22]
In December 2024, several NSCEB policy ideas were passed into law as part of the FY25 NDAA.[23] [24]
In February 2025, the Special Competitive Studies Project announced a joint event to be held in April 2025 with the NSCEB to mark the publication of the Commission's final policy report.[25]
References
[edit ]- ^ "Statement by the President on S. 1605, the National Defense Authorization Act for Fiscal Year 2022". 27 December 2021.
- ^ a b "Armed Services Committees Leadership Announces Selections for National Security Commission on Emerging Biotechnology | United States Committee on Armed Services". www.armed-services.senate.gov. 17 March 2022. Retrieved 2022年03月19日.
- ^ https://www.biotech.senate.gov/
- ^ SCSP (2025年02月28日). "What's Happening at SCSP? Can't Miss Announcements". Special Competitive Studies Project. Retrieved 2025年03月11日.
- ^ "Young Named to National Security Commission on Emerging Biotechnology | U.S. Senator Todd Young of Indiana". www.young.senate.gov. Retrieved 2022年03月19日.
- ^ Staff, Bio News (2024年09月27日). "Exclusive: Sen. Todd Young on biosecurity, National Security Commission on Emerging Biotechnology (NSCEB)". Bio.News. Retrieved 2024年10月26日.
- ^ "Virtual Event | Biopower: Securing American Leadership in Biotechnology". CNAS. Retrieved 2025年03月13日.
- ^ "Bio-Strategies And Leadership Holds Inaugural Congressional Fellowship Program On Biotechnology Strategy". Hoover Institution. Retrieved 2025年03月11日.
- ^ "Lawmakers name appointees to new emerging biotech panel | InsideDefense.com". insidedefense.com. Retrieved 2022年03月19日.
- ^ "Bice Selected for National Security Commission on Emerging Biotechnology". Representative Stephanie Bice. 2022年03月17日. Retrieved 2022年03月19日.
- ^ "Indian-American Ro Khanna named to emerging biotechnology body". The American Bazaar. 2022年03月18日. Retrieved 2022年03月19日.
- ^ "The Hon. Dov S. Zakheim - Foreign Policy Research Institute". www.fpri.org. Retrieved 2022年03月19日.
- ^ "National Security Commission for Emerging Biotechnology Sounds the Alarm | AFCEA International". www.afcea.org. 2024年12月02日. Retrieved 2025年01月09日.
- ^ Cumbers, John. ""With Great Power Comes Great Responsibility" — Meet Alexander Titus The Department Of Defense's Head Of Biotechnology". Forbes. Retrieved 2022年03月19日.
- ^ "Armed Services Committees Leadership Announces Chair and Vice Chair Selections for National Security Commission on Emerging Biotechnology | United States Senate Committee on Armed Services". 30 December 2022.
- ^ "Bio Page - Dawn Meyerriecks".
- ^ "December 2023 New Report". Biotech. Retrieved 2024年01月19日.
- ^ "New Biotech Commission Issues Interim Report". AIP. 2024年01月16日. Retrieved 2024年02月01日.
- ^ "NSCEB Interim Report" (PDF). National Security Commission on Emerging Biotechnology. 2023年12月01日. Retrieved 2024年12月18日.
- ^ "AIxBio White Paper 1: Introduction to AI and Biotech". Biotech. Retrieved 2024年01月27日.
- ^ Dalton, Jack (2025年01月07日). "Innovation for security: why Australia needs its own DARPA". The Strategist. Retrieved 2025年03月13日.
- ^ "Padilla, Young Introduce Bills on Intersection of Biotech, Agriculture, and National Security". Senator Alex Padilla. Retrieved 2024年10月26日.
- ^ "National Security Commission on Emerging Biotechnology Announces FY25 NDAA Biotechnology Provisions". Biotech. Retrieved 2025年01月09日.
- ^ "FY25 NDAA Includes Biotech Recommendations for DOD". natlawreview.com. Retrieved 2025年01月09日.
- ^ SCSP (2025年02月28日). "What's Happening at SCSP? Can't Miss Announcements". Special Competitive Studies Project. Retrieved 2025年03月13日.